Search Results 1341-1350 of 18292 for Topical

1. A Study to Evaluate Intravenous Iloprost in Subjects with Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis - Mayo Clinic

   Subjects who have initiated or had a dose change of any of the following within 2 weeks of screening: oral, topical, or intravenous (IV) vasodilators (e.g. ...

2. Pyrantel (oral route) - Side effects & dosage - Mayo Clinic

   Pyrantel belongs to the family of medicines called anthelmintics. Anthelmintics are used in the treatment of worm infections. Pyrantel is used to treat pinworms ...

3. Study Evaluating the Safety and Effectiveness of JCARH125 in Subjects with Relapsed and/or Refractory Multiple Myeloma (EVOLVE) - Mayo Clinic

   Physiologic replacement, topical, and inhaled steroids are permitted;; Radiation to a single lesion within 14 days before leukapheresis;; Radiation that ...

4. Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH) - Mayo Clinic

   Ingestible or topical marijuana is allowed, per local restrictions and regulations. Documented history of alcohol abuse and/or history of utilizing drugs of ...

5. A Study of Using Palbociclib Combined with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive/ Human Epidermal Growth Factor Receptor 2 Negative Early Breast Cancer - Mayo Clinic

   Receiving concurrent exogenous hormone therapy (topical vaginal estrogen therapy is allowable). Participating Mayo Clinic locations. Study statuses change ...

6. A Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD Patients - Mayo Clinic

   ... topical steroids), or any medication that may cause cataract, according to the Prescribing Information. The patient has received strong or moderate inducers ...

7. Trial of Intravesical Measles Virotherapy in Patients With Bladder Cancer Who Are Undergoing Radical Cystectomy - Mayo Clinic

   Inhaled or topical steroids, and adrenal replacement doses > 10 mg daily prednisone equivalents are permitted in the absence of active autoimmune disease.

8. IFX_HU2.0 As An Adjunctive Therapy To Pembrolixumab In Checkpoint Inhibitor Naive Subjects With Advanced Or Metastatic Merkel Cell Carcinoma - Mayo Clinic

   Inhaled or topical steroids are permitted in the absence of active autoimmune disease. Note: Other protocol defined Inclusion/Exclusion Criteria may apply ...

9. Cough Clinic employs novel pharmacologics to address unexplained or refractory chronic cough - Mayo Clinic

   We often consider using a topical anesthetic such as a tetracaine lollipop, a formulation that was developed at Mayo Clinic that is compounded at Mayo ...

10. Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors - Mayo Clinic

    Participation eligibility · Adrenal replacement (dose of ≤10 mg daily of prednisone or equivalent); · Topical, ocular, intra-articular, intranasal, or ...